These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 835219)

  • 1. After-effect of injection.
    Nelson M
    Vet Rec; 1977 Jan; 100(4):78. PubMed ID: 835219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. After-effect of injection.
    Janssens LA
    Vet Rec; 1977 Jan; 100(2):35. PubMed ID: 836606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioimmunoassay for medroxyprogesterone acetate (Provera) using the 11alpha-hydroxy succinyl conjugate.
    Royer ME; Ko H; Campbell JA; Murray HC; Evans JS; Kaiser DG
    Steroids; 1974 May; 23(5):713-30. PubMed ID: 4365969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioimmunoassay of serum medroxyprogesterone acetate (Provera) in women following oral and intravaginal administration.
    Hiroi M; Stanczyk FZ; Goebelsmann U; Brenner PF; Lumkin ME; Mishell DR
    Steroids; 1975 Sep; 26(3):373-86. PubMed ID: 1198624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma medroxyprogesterone acetate levels following intramuscular or oral administration in patients with endometrial adenocarcinoma.
    Laatikainen T; Nieminen U; Adlercreutz H
    Acta Obstet Gynecol Scand; 1979; 58(1):95-9. PubMed ID: 419965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of monthly depot medroxyprogesterone acetate and testosterone on human spermatogenesis. I. Uniform dosage levels.
    Frick J; Bartsch G; Weiske WH
    Contraception; 1977 Jun; 15(6):649-68. PubMed ID: 891192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of breast cancer with medroxyprogesterone acetate.
    Muggia FM; Cassieth PA; Ochoa M; Flatow FA; Gellhorn A; Hyman GA
    Ann Intern Med; 1968 Feb; 68(2):328-37. PubMed ID: 4306126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unsuccessful treatment of acromegaly with medroxyprogesterone acetate.
    Atkinson RL; Dimond RC; Howard WJ; Earll JM
    Acta Endocrinol (Copenh); 1974 Sep; 77(1):19-25. PubMed ID: 4408390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of seizures with medroxyprogesterone acetate: preliminary report.
    Mattson RH; Cramer JA; Caldwell BV; Siconolfi BC
    Neurology; 1984 Sep; 34(9):1255-8. PubMed ID: 6540415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of medroxyprogesterone acetate and testosterone enanthate as a male contraceptive.
    Brenner PF; Mishell DR; Bernstein GS; Ortiz A
    Contraception; 1977 Jun; 15(6):679-91. PubMed ID: 891194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids: noresthisterone oenanthate and medroxyprogesterone acetate. 2. Bleeding patterns and side effects.
    Contraception; 1978 May; 17(5):395-406. PubMed ID: 657807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunoassay for serum medroxyprogesterone acetate in Thai women receiving injectable DMPA contraceptive.
    Werawatgoompa S; Pongpradit T; Leepipatpaiboon S; Sukanthanak A
    Contraception; 1979 Oct; 20(4):319-27. PubMed ID: 509958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogenic activity in women receiving an injectable progestogen for contraception.
    Mishell DR; Kharma KM; Thorneycroft IH; Nakamura RM
    Am J Obstet Gynecol; 1972 Jun; 113(3):372-6. PubMed ID: 4637029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct effects of medroxyprogesterone acetate (MPA) and megestrol acetate (MGA) on rat testicular steroidogenesis.
    Barbieri RL; Ryan KJ
    Acta Endocrinol (Copenh); 1980 Jul; 94(3):419-25. PubMed ID: 6968496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism of action of an antifertility vaccine in the rhesus monkey: reversal of the effects of antisera to the beta-subunit of ovine luteinizing hormone by medroxyprogesterone acetate.
    Thau RB; Sundaram K
    Fertil Steril; 1980 Mar; 33(3):317-20. PubMed ID: 6767627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High dose medroxyprogesterone acetate (MPA) treatment in metastatic carcinoma of the breast: a dose-response evaluation.
    Cuna GR; Calciati A; Strada MR; Bumma C; Campio L
    Tumori; 1978 Apr; 64(2):143-9. PubMed ID: 354147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contraceptive and endometrial effects of medroxyprogesterone acetate.
    Lee RA
    Am J Obstet Gynecol; 1969 May; 104(1):130-3. PubMed ID: 5777697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ultrastructural response of human endometrium to medroxyprogesterone acetate.
    Roberts DK; Horbelt DV; Powell LC
    Am J Obstet Gynecol; 1975 Dec; 123(8):811-8. PubMed ID: 173189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
    Contraception; 1982 Jan; 25(1):1-11. PubMed ID: 6460593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.